Clinical trial
CUTE (Chronic Urticaria Treatment Evaluation)
NCT00264303 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00264303 |
|---|---|
| Title | CUTE (Chronic Urticaria Treatment Evaluation) |
| Official title | A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU) |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Idiopathic Urticaria |
| Intervention type | Drug |
| Interventions | Levocetirizine, Desloratadine |
| Enrollment | 886 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Dec 12, 2005 |
| Last update posted | Aug 31, 2011 |
| Countries | Belgium, France, Germany, Italy, Malaysia, Romania, South Africa, Spain, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: